KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Neogenomics (NEO) Other Gross PP&E Adjustments (2016 - 2026)

Neogenomics filings provide 16 years of Other Gross PP&E Adjustments readings, the most recent being -$99.6 million for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 3.09% to -$99.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$99.6 million, a 3.09% increase, with the full-year FY2025 number at $210.5 million, up 4.92% from a year prior.
  • Other Gross PP&E Adjustments hit -$99.6 million in Q1 2026 for Neogenomics, down from $210.5 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $210.5 million in Q4 2025 to a low of -$127.3 million in Q1 2022.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$99.6 million (2026), compared with a mean of -$39.1 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 118.52% in 2022 and later rose 28.76% in 2024.
  • Neogenomics' Other Gross PP&E Adjustments stood at $135.5 million in 2022, then rose by 14.99% to $155.8 million in 2023, then rose by 28.76% to $200.6 million in 2024, then grew by 4.92% to $210.5 million in 2025, then plummeted by 147.31% to -$99.6 million in 2026.
  • The last three reported values for Other Gross PP&E Adjustments were -$99.6 million (Q1 2026), $210.5 million (Q4 2025), and -$87.8 million (Q3 2025) per Business Quant data.